Richard A. Paulson, President and CEO at Karyopharm Therapeutics Inc. (KPTI), sold 3,675 shares at $0.91 ($3K) on 2024-11-05, disclosed to the SEC on 2024-11-06.
Open-market sale of $3k KPTI by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| KPTI | SELL | 2025-09-16 | $8K | — | Filing → |
| KPTI | SELL | 2025-05-07 | $2K | — | Filing → |
| KPTI | SELL | 2025-04-07 | $916 | — | Filing → |